Home LiteratureArticle Details
PMID: 15774470 Published · ppublish English Journal Article

A3 adenosine receptor activation inhibits cell proliferation via phosphatidylinositol 3-kinase/Akt-dependent inhibition of the extracellular signal-regulated kinase 1/2 phosphorylation in A375 human melanoma cells.

The Journal of biological chemistry ·Vol. 280 ·No. 20 ·2005-05-20 ·Pages 19516-26

Merighi S, Benini A, Mirandola P, Gessi S, Varani K, Leung E, Maclennan S, Borea PA

Abstract

Adenosine exerts its effects through four subtypes of G-protein-coupled receptors: A(1), A(2A), A(2B), and A(3). Stimulation of the human A(3) receptor has been suggested to influence cell death and proliferation. The phosphatidylinositide-3-OH kinase (PI3K)/Akt and the Raf/mitogen-activated protein kinase (MAPK/ERK) kinase (MEK)/mitogen-activated protein kinase (MAPK) pathways have central roles in the regulation of cell survival and proliferation. Due to their importance, the cross-talk between these two pathways has been investigated. Here, we show that the A(3) adenosine receptor agonist Cl-IB-MECA stimulates PI3K-dependent phosphorylation of Akt leading to the reduction of basal levels of ERK1/2 phosphorylation, which in turn inhibits cell proliferation. The response to Cl-IB-MECA was not blocked by A(1), A(2A), or A(2B) receptor antagonists, although it was abolished by A(3) receptor antagonists. Furthermore, the response to Cl-IB-MECA was generated at the cell surface, since the inhibition of A(3) receptor expression, by using small interfering RNA, abolished agonist effects. Using A375 cells, we show that A(3) adenosine receptor stimulation results in PI3K-dependent phosphorylation of Akt, leading to the reduction of basal levels of ERK1/2 phosphorylation, which in turn inhibits cell proliferation.

MeSH Terms
Adenosine/analogs & derivatives,pharmacology Adenosine A3 Receptor Agonists Adenosine A3 Receptor Antagonists Base Sequence Cell Division/drug effects Cell Line, Tumor Humans MAP Kinase Signaling System/drug effects Melanoma/metabolism,pathology Mitogen-Activated Protein Kinase 1/antagonists & inhibitors Mitogen-Activated Protein Kinase 3/antagonists & inhibitors Phosphatidylinositol 3-Kinases/metabolism Phosphorylation Protein Serine-Threonine Kinases/metabolism Proto-Oncogene Proteins/metabolism Proto-Oncogene Proteins c-akt RNA, Small Interfering/genetics Receptor, Adenosine A3/genetics,metabolism
Chemicals
Adenosine A3 Receptor Agonists Adenosine A3 Receptor Antagonists Proto-Oncogene Proteins RNA, Small Interfering Receptor, Adenosine A3 AKT1 protein, human Protein Serine-Threonine Kinases Proto-Oncogene Proteins c-akt Mitogen-Activated Protein Kinase 1 Mitogen-Activated Protein Kinase 3 Adenosine 2-chloro-N(6)-(3-iodobenzyl)adenosine-5'-N-methyluronamide
Authors & Affiliations
8 authors, click to expand affiliations / ORCID
Merighi Stefania
Department of Clinical and Experimental Medicine, Pharmacology Unit, University of Ferrara, Italy.
Benini Annalisa
Mirandola Prisco
Gessi Stefania
Varani Katia
Leung Edward
Maclennan Stephen
Borea Pier Andrea
Article Info
Journal
The Journal of biological chemistry
Abbr.
J Biol Chem
ISSN
0021-9258
Published
2005-05-20
Epub
2005-00-17
Pages
19516-26
Language
English
Region
United States
NLM ID
2985121R
Subset
IM
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: [email protected]